These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1661135)

  • 21. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
    Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
    Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
    Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
    J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
    J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
    Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
    J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression.
    Cullen KJ; Lippman ME; Chow D; Hill S; Rosen N; Zwiebel JA
    Mol Endocrinol; 1992 Jan; 6(1):91-100. PubMed ID: 1310798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and hormonal regulation of radioimmunoassayable IGF-I (insulin-like growth factor I) like activity and IGF-binding proteins secreted by human breast cancer cells.
    Ahmed SR; Manni A; Gray G; Hammond JM
    Anticancer Res; 1990; 10(5A):1217-23. PubMed ID: 1700662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression.
    Miller DL; el-Ashry D; Cheville AL; Liu Y; McLeskey SW; Kern FG
    Cell Growth Differ; 1994 Dec; 5(12):1263-74. PubMed ID: 7696175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells.
    Huff KK; Kaufman D; Gabbay KH; Spencer EM; Lippman ME; Dickson RB
    Cancer Res; 1986 Sep; 46(9):4613-9. PubMed ID: 3731113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
    Kassem M; Okazaki R; De León D; Harris SA; Robinson JA; Spelsberg TC; Conover CA; Riggs BL
    Proc Assoc Am Physicians; 1996 Mar; 108(2):155-64. PubMed ID: 8705735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased autocrine production of insulin-like growth factor II (IGF-II) alters serum sensitivity of MCF-7 human breast cancer cell proliferation.
    Corcoran D; Perachiotti A; Darbre PD
    Cell Prolif; 1996 Sep; 29(9):479-93. PubMed ID: 8980655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The monoclonal HBA-71 antibody modulates proliferation of thymocytes and Ewing's sarcoma cells by interfering with the action of insulin-like growth factor I.
    Hamilton G; Mallinger R; Hofbauer S; Havel M
    Thymus; 1991 Aug; 18(1):33-41. PubMed ID: 1656551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.
    Abdul-Wahab K; Corcoran D; Perachiotti A; Darbre PD
    Cell Prolif; 1999 Oct; 32(5):271-87. PubMed ID: 10619489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol.
    Daws MR; Westley BR; May FE
    Endocrinology; 1996 Apr; 137(4):1177-86. PubMed ID: 8625887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence.
    Brünner N; Moser C; Clarke R; Cullen K
    Breast Cancer Res Treat; 1992; 22(1):39-45. PubMed ID: 1421423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.